Alyssa Everson, PA
Physician Assistant · Burnsville, MNNPI 1093335796
Payments from drug & device makers
Across 59 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$107
- Acadia Pharmaceuticals Inc$95
- UCB, Inc.$93
- Argenx US, Inc.$65
- Biogen$63
- Amneal Pharmaceuticals LLC$61
- plus $690 from 23 others
What the payments were for
- Food & beverage$1,174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 4 | $107 |
| Acadia Pharmaceuticals Inc | 5 | $95 |
| UCB, Inc. | 5 | $93 |
| Argenx US, Inc. | 4 | $65 |
| Biogen | 4 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $58 |
| AbbVie | 3 | $49 |
| AstraZeneca | 2 | $47 |
| EMD Serono, Inc. | 2 | $41 |
| Novartis | 2 | $39 |
| NS Pharma, Inc. | 1 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Bristol Myers Squibb | 1 | $35 |
| Tanabe Pharma America, Inc. | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Neurelis, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $21 |
| Pfizer | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
| Philips North America LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| TG Therapeutics, Inc. | 1 | $17 |
| CSL Behring | 1 | $17 |
| Hospira, Inc. | 1 | $14 |
How this compares
$1,174 in reported general payments places this provider in the 90th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 46 | $1,708 |
| Memantine Hcl | 32 | $1,259 |
| Gabapentin | 82 | $1,240 |
| Levetiracetam | 24 | $1,176 |
| Lamotrigine | 17 | $1,012 |
| Pregabalin | 43 | $783 |
| Topiramate | 19 | $341 |
| Donepezil Hcl | 30 | $250 |
| Quetiapine Fumarate | 13 | $173 |
| Clonazepam | 15 | $9 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Burnsville
- Daniel NguyenBurnsville$8K
- Robyn KunkelBurnsville$4K
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Kenneth MitchellWoodbury$87K
- Jennifer SutherlandMinneapolis$65K
- George FroehleMinneapolis$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.